| T35557 |
CK2 inhibitor 2
|
2641079-92-5
|
98%
|
|
|
CK2 Inhibitor 2, characterized as a potent, selective, and orally active inhibitor of CK2, demonstrates an impressive IC50 value of 0.66 nM. It exhibits high sel...
|
| T14072 |
A-443654
|
552325-16-3
|
|
|
|
A-443654 is a pan-Akt inhibitor. A-443654 has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM).
|
| T1877 |
LH846
|
639052-78-1
|
|
|
|
LH846 is a selective inhibitor of CK1δ (IC50 values are 290 nM, 1.3 uM and 2.5 uM for CK1δ, ε and α); exhibits no inhibitory activity at CK2.
|
| T8987 |
Epiblastin A
|
16470-02-3
|
100%
|
|
|
Epiblastin A is an inhibitor of Casein Kinase 1 (CK1). Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells...
|
| T3972 |
SR-3029
|
1454585-06-8
|
100%
|
|
|
SR-3029 is a potent and highly specific CK1δ/CK1ε inhibitor.
|
| T19913 |
CKI-7
|
1177141-67-1
|
100.00%
|
|
|
CKI-7 is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ...
|
| T2869 |
Emodin
|
518-82-1
|
94.4%
|
|
|
Emodin (Frangula emodin) is a naturally occurring anthraquinone present in the roots and barks of numerous plants; exerts antiproliferative effects in Y cells th...
|
| T10547 |
BioE-1115
|
1268863-35-9
|
97.38%
|
|
|
BioE-1115 is a selective and potent inhibitor of serine-threonine protein kinase (PASK, IC50 = 4 nM). BioE-1115 is a potent inhibitor of CK2α (IC50 = 10 μM).
|
| T1828 |
TTP 22
|
329907-28-0
|
97.78%
|
|
|
TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM, and shows selectivity >250-fold for CK2 over JNK3, ROCK1...
|
| T73269 |
CK2α-IN-1
|
443747-52-2
|
98%
|
|
|
CK2α-IN-1 is a selective non-ATP-competitive CK2α inhibitor with an IC50 of 7.0 µM and a Ki of 1.6 µM.CK2α-IN-1 exhibits potential anticancer activity and can be...
|
| T7949 |
NCC007
|
2342583-66-6
|
98.11%
|
|
|
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.
|
| T5056 |
PF-4800567
|
1188296-52-7
|
98.23%
|
|
|
PF-4800567 is a selective inhibitor of casein kinase 1ε (CK1ε; IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.
|
| T12237 |
NMS-P715
|
1202055-32-0
|
98.41%
|
|
|
NMS-P715 is a selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
|
| T77708 |
Casein kinase 1δ-IN-7
|
764694-25-9
|
98.6%
|
|
|
Casein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.
|
| T13004 |
SSTC3
|
1242422-09-8
|
98.65%
|
|
|
SSTC3 is a casein kinase 1α (CK1α) activator with a Kd of 32 nM.SSTC3 has potential antitumor activity, inhibits WNT signaling, and suppresses SHH medulloblastom...
|
| T60005 |
CK1-IN-3
|
349438-74-0
|
98.70%
|
|
|
CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, infla...
|
| T5393 |
CK1-IN-1
|
1784751-20-7
|
98.79%
|
|
|
CK1-IN-1 (PUN51207) is a casein kinase 1 (CK1) inhibitor. CK1-IN-1 has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively.
|
| T10687 |
Casein Kinase II Inhibitor IV
|
863598-09-8
|
98.81%
|
|
|
Casein Kinase II Inhibitor IV is an inducer of epidermal keratinocyte differentiation.
|
| T10827 |
CK2/ERK8-IN-1
|
1085822-09-8
|
98.82%
|
|
|
CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds t...
|
| T77500 |
Casein kinase 1δ-IN-6
|
1579991-01-7
|
99%
|
|
|
Casein kinase 1δ-IN-6 is a potent and selective inhibitor of the protein kinase CK-1δ with an IC50 of 23 nM.Casein kinase 1δ-IN-6 shows neuroprotective and anti-...
|
